Akeso, Summit's PD-1xVEGF drug meets overall survival goal for the first time in a lung cancer trial
For the first time, Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody has shown that it can extend patients’ lives. A “statistically significant and clinically meaningful” ...
Researchers have announced the creation of the first operating system designed for quantum networks: QNodeOS. The research marks a major step forward in transforming quantum networking from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback